RelmanDAFalkowS. A molecular perspective of microbial pathogenicity. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Philadelphia, PA: Elsevier, 2015, pp. 1–10.
2.
SeifertHS. Location, location, location—commensalism, damage and evolution of the pathogenic Neisseria. J Mol Biol2019; 431(16): 3010–3014.
3.
CornelissenCN. Molecular pathogenesis of Neisseria gonorrhoeae. Frontiers in Microbiology2011; 2224.
4.
van BergenJEHoenderboomBMDavidS, et al.Where to go to in chlamydia control? From infection control towards infectious disease control. Sex Transm Infect2021; 97(7): 501–506.
5.
KenyonCHerrmannBHughesG, et al.Management of asymptomatic sexually transmitted infections in Europe: towards a differentiated, evidence-based approach. Lancet Reg Health Eur2023; 34: 100743.
6.
CasadevallAPirofskiL-A. Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity. Infect Immun1999; 67(8): 3703–3713.
7.
CasadevallAPirofskiL-A. Host-pathogen interactions: basic concepts of microbial commensalism, colonization, infection, and disease. Infect Immun2000; 68(12): 6511–6518.
HuttenhowerCGeversDKnightR, et al.Structure, function and diversity of the healthy human microbiome. Nature2012; 486(7402): 207–214.
10.
HeinonenPKMiettinenA. Laparoscopic study on the microbiology and severity of acute pelvic inflammatory disease. Eur J Obstet Gynecol Reprod Biol1994; 57(2): 85–89.
11.
BrunhamRBinnsBGuijonF, et al.Etiology and outcome of acute pelvic inflammatory disease. J Infect Dis1988; 158(3): 510–517.
12.
VanbaelenTTsoumanisAFlorenceE, et al.Effect of screening for Neisseria gonorrhoeae and Chlamydia trachomatis on incidence of these infections in men who have sex with men and transgender women taking HIV pre-exposure prophylaxis (the Gonoscreen study): results from a randomised, multicentre, controlled trial. Lancet HIV2024; 11: e233–e244. DOI: 10.1016/S2352-3018(23)00299-0.
13.
BarbeeLAKhosropourCMSogeOO, et al.The natural history of rectal gonococcal and chlamydial infections: the ExGen study. Clin Infect Dis2022; 74(9): 1549–1556.
14.
VuylstekeBReyniersTDe BaetselierI, et al.Daily and event‐driven pre‐exposure prophylaxis for men who have sex with men in Belgium: results of a prospective cohort measuring adherence, sexual behaviour and STI incidence. J Int AIDS Soc2019; 22(10): e25407.
15.
TsoumanisAHensNKenyonCR. Is screening for chlamydia and gonorrhea in men who have sex with men associated with reduction of the prevalence of these infections? A systematic review of observational studies. Sex Transm Dis2018; 45(9): 615–622. DOI: 10.1097/OLQ.0000000000000824.
16.
TsoumanisAVan DijckCHensN, et al.Rethinking screening intensity in terms of reducing prevalence or increasing selection pressure for the emergence of resistant gonorrhea: a modeling study of men who have sex with men in Belgium. Open Forum Infect Dis2023; 10(4): ofad165. DOI: 10.1093/ofid/ofad165.
17.
MarcusUMirandolaMSchinkSB, et al.Changes in the prevalence of self-reported sexually transmitted bacterial infections from 2010 and 2017 in two large European samples of men having sex with men–is it time to re-evaluate STI-screening as a control strategy?PLoS One2021; 16(3): e0248582.
18.
Van DijckCLaumenJZlotorzynskaM, et al.Association between STI screening intensity in men who have sex with men and gonococcal susceptibility in 21 States in the USA: an ecological study. Sex Transm Infect2020; 96(7): 537–540. DOI: 10.1136/sextrans-2019-054313.
19.
KenyonCDe BaetselierIWoutersK. Screening for STIs in PrEP cohorts results in high levels of antimicrobial consumption. Int J STD AIDS2020; 31(12): 956462420957519.
20.
TongSYDavisJSEichenbergerE, et al.Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev2015; 28(3): 603–661.
21.
LaumenJGEVan DijckCAbdellatiS, et al.Antimicrobial susceptibility of commensal Neisseria in a general population and men who have sex with men in Belgium. Sci Rep2022; 12(9): 9.
22.
KenyonC. To what extent should we rely on antibiotics to reduce high gonococcal prevalence? Historical insights from mass-meningococcal campaigns. Pathogens2020; 9(2): 134.
23.
WestonEJHeidengaBLFarleyMM, et al.Surveillance for disseminated gonococcal infections, active bacterial core surveillance (ABCs)—United States, 2015–2019. Clin Infect Dis2022; 75(6): 953–958.
24.
LowNBenderNNarteyL, et al.Effectiveness of chlamydia screening: systematic review. Int J Epidemiol2009; 38(2): 435–448.
25.
MorrisANorrisKA. Colonization by Pneumocystis jirovecii and its role in disease. Clin Microbiol Rev2012; 25(2): 297–317.
26.
CoverTLBlaserMJ. Helicobacter pylori in health and disease. Gastroenterology2009; 136(6): 1863–1873.
27.
WetmoreCMManhartLELowensMS, et al.Ureaplasma urealyticum is associated with nongonococcal urethritis among men with fewer lifetime sexual partners: a case-control study. J Infect Dis2011; 204(8): 1274–1282.
28.
LookerKJJohnstonCWeltonNJ, et al.The global and regional burden of genital ulcer disease due to herpes simplex virus: a natural history modelling study. BMJ Glob Health2020; 5(3): e001875.
29.
HookIIIEWHandsfieldHH. Gonococcal infections in the adult. KING K HOLMES, MD, PhD 2005;5:627.